ICH S6 (R1) Preclinical safety evaluation of biotechnology-derived pharmaceuticals

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Reference numberCHMP/ICH/731268/1998
Effective from01/03/1998
KeywordsNon-clinical safety, biotechnology-derived pharmaceuticals, species selection, pharmacokinetics, toxicology
DescriptionThis document aims to recommend a basic framework for the preclinical safety evaluation of biotechnology-derived pharmaceuticals. It applies to products derived from characterised cells through the use of a variety of expression systems including bacteria, yeast, insect, plant, and mammalian cells.

Related content

How helpful is this page?

Average rating:

 Based on 47 ratings

Add your rating:

See all ratings
9 ratings
9 ratings
9 ratings
9 ratings
11 ratings

Tell us more